Evidence map›Paper›PMID 35653568›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4

Wei-Le Wang, Jun Kasamatsu, Satoru Joshita, Susan Gilfillan, Blanda Di Luccia, Santosh K Panda, Do-Hyun Kim, Pritesh Desai, Jennifer K Bando, Stanley Ching-Cheng Huang and 8 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Tissue adaptation of eosinophils.Journal of leukocyte biology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wei-Le WangDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.ORCID 0000-0002-6984-4514
Jun KasamatsuDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Satoru JoshitaDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.ORCID 0000-0003-1672-0996
Blanda Di LucciaDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Santosh K PandaDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Do-Hyun KimDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Pritesh DesaiDepartment of Medicine, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Jennifer K BandoDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.ORCID 0000-0002-1331-7424
Stanley Ching-Cheng HuangDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Kentaro YomogidaDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Hitomi HoshinoDepartment of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, 910-1193 Eiheiji, Japan.
Mana FukushimaDepartment of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, 910-1193 Eiheiji, Japan.
Elizabeth A JacobsenDivision of Allergy, Asthma and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ 85259.
Steven J Van DykenDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.ORCID 0000-0002-9787-0883
Christiane RuedlSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.ORCID 0000-0002-5599-6541
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110.ORCID 0000-0001-5222-4987

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Mucosal Immune Defense Mechanisms of the Urinary BladderU01AI095542 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, HULTGREN, SCOTT J. · 2011 to 2020
$9.8M
TRAINING IN THE IMMUNOLOGY OF RHEUMATIC DISEASEST32AR007279 · NIAMS · WASHINGTON UNIVERSITY · PI Megan Anne Cooper, Deborah J Lenschow · 1986 to 2026
$6.0M
Impact of Aiolos on intestinal intraepithelial lymphocytesK08DK128544 · NIDDK · WASHINGTON UNIVERSITY · PI Kentaro Yomogida · 2022 to 2026
$807k
Immune Checkpoints for Intestinal Innate Lymphoid CellsR00DK118110 · NIDDK · STANFORD UNIVERSITY · PI BANDO, JENNIFER KAORU · 2021 to 2023
$747k
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NIAID NIH HHS U01 AI095542NIAMS NIH HHS T32 AR007279NIDDK NIH HHS K08 DK128544NIDDK NIH HHS R00 DK118110
6 · The paper itself

Abstract

C-type lectin domain family 4, member a4 (Clec4a4) is a C-type lectin inhibitory receptor specific for glycans thought to be exclusively expressed on murine CD8α− conventional dendritic cells. Using newly generated Clec4a4-mCherry knock-in mice, we identify a subset of Clec4a4-expressing eosinophils uniquely localized in the small intestine lamina propria. Clec4a4+ eosinophils evinced an immunomodulatory signature, whereas Clec4a4− eosinophils manifested a proinflammatory profile. Clec4a4+ eosinophils expressed high levels of aryl hydrocarbon receptor (Ahr), which drove the expression of Clec4a4 as well as other immunomodulatory features, such as PD-L1. The abundance of Clec4a4+ eosinophils was dependent on dietary AHR ligands, increased with aging, and declined in inflammatory conditions. Mice lacking AHR in eosinophils expanded innate lymphoid cells of type 2 and cleared Nippostrongylus brasiliensis infection more effectively than did wild-type mice. These results highlight the heterogeneity of eosinophils in response to tissue cues and identify a unique AHR-dependent subset of eosinophils in the small intestine with an immunomodulatory profile.

Indexed as

EosinophilsReceptors, Aryl HydrocarbonReceptors, Cell SurfaceEosinophiliaFood HypersensitivityImmunomodulationIntestine, SmallLeukocyte CountLigandsLigandsReceptors, Aryl HydrocarbonReceptors, Cell Surfaceallergyaryl hydrocarbon receptoreosinophilhelminthintestine

Identifiers

PMID35653568
PMCPMC9191779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.